Company / Operating Cash Flow per Share
PALVELLA THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.87
FY2024
5-year range
-$4.87 / -$0.18
FY2020-FY2024
Trend
-2548.3%
vs FY2023
Sector context
#198 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -2548% YoY in FY2024, a notable deviation from the 9-year average annual change of -238%.
Based on SEC 10-K filings.
-4.87 in FY2024.
Declined from $-0.83 to $-4.87 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 212This company -$4.87 Sector average $5.28
▼
-192.3% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 2548.3% year-over-year.
- Ranks #198 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$4.87 | -2548.3% |
| FY2023 | -$0.18 | +77.8% |
| FY2022 | -$0.83 | -1.3% |
| FY2021 | -$0.82 | +13.8% |
| FY2020 | -$0.95 | +1.9% |
| FY2019 | -$0.97 | -187.7% |
| FY2018 | $1.11 | +430.8% |
| FY2017 | -$0.33 | +7.5% |
| FY2016 | -$0.36 | +60.6% |
| FY2015 | -$0.92 | -70588.5% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026